AEGiS-AP: CDC Making Transplant Guides Associated PressImportant note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.
Click here to return to Associated Press main menu




DonateNow



CDC Making Transplant Guides

The Associated Press - 18 Dec 95; 50 Rockefeller Plaza, New York, NY 10020.


ATLANTA (AP) -- Amid concerns over the recent transplant of baboon tissue into an AIDS patient, the nation's health agencies are developing guidelines to make sure such operations don't spread devastating new infections.

The question of whether animal transplants would foster new diseases among humans isn't just academic, according to Dr. Louisa Chapman, an epidemiologist with the Centers for Disease Control who is working on the guidelines.

More than 150 diseases can be transmitted from animals to humans, including rabies, and some become deadlier in humans. Some researchers believe the deadly 1918-19 flu pandemic was caused by a virus that spread from pig to humans, and AIDS is believed to have jumped fom monkeys to man.

The issue came to a head this year when the Food and Drug Administration delayed the baboon-to-human transplant until it determined the experiment's safety. San Francisco AIDS patient Jeff Getty received the baboon bone marrow cells on Thursday.

"This is a new world of infection possibilities," Chapman said, adding that the biggest concern is another pandemic like AIDS.

"It probably won't happen, but it would be an event that could have a tremendously adverse public health impact," she said.

The CDC decided to develop guidelines because of the growing belief among scientists that animal-to-human transplants -- called xenotransplants -- might one day help to solve the nation's critical organ shortage.

That day is not near -- researchers have yet to overcome the rejection of animal tissue by a human patient's immune system -- but the CDC and the FDA want to be prepared.

"Without question this is something that requires federal oversight and guidelines, primarily because of the public health implications," said Dr. Steven Deeks of the University of California, San Francisco, who is the lead clinician for Getty. "There's a large risk to the recipient, and although the risks to the public are negligible, there are unknowns."

Other xenotransplant experts say the government has no reason to intervene, and they accuse the CDC and FDA of exaggerating the danger.

The danger in using non-primates, such as pigs, is remote, said Dr. Mark Hardy of the Columbia-Presbyterian Medical Center. For one thing, these animals are raised in carefully controlled environments, he argued.

However, he agreed that guidelines concerning primates such as baboons and monkeys -- which are more closely related to humans -- are important. "We need to be concerned about that," he said.

The guidelines, which are in the final stages and will soon be published for public comment, set goals for transplant centers. They will be asked to uphold levels of expertise and safety, select animals to minimize the risk of infection, monitor patients after an operation to detect infection, and collect data on transplant recipients to determine if the government's public health concerns are valid.

The guidelines won't be law, but most centers are expected to follow them.

Copyright 1995/The Associated Press. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, The Associated Press, 50 Rockefeller Plaza, New York, NY 10020.


951218
AP951221


Copyright © 1995 - Associated Press. Reproduction of this article (other than one copy for personal reference) must be cleared through the AP Permissions Desk.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, National Library of Medicine, Pacific Life Foundation, and donations from users like you.

Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .